Risk of early‐ and late‐onset Alzheimer disease and related dementia in adults with cerebral palsy
Aim To examine the risk of Alzheimer disease and related dementia (ADRD) among adults with cerebral palsy (CP). Method Using administrative insurance claims data for 2007 to 2017 in the USA, we identified adults (45y or older) with a diagnosis of CP (n=5176). Adults without a diagnosis of CP were in...
Saved in:
Published in | Developmental medicine and child neurology Vol. 64; no. 3; pp. 372 - 378 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aim
To examine the risk of Alzheimer disease and related dementia (ADRD) among adults with cerebral palsy (CP).
Method
Using administrative insurance claims data for 2007 to 2017 in the USA, we identified adults (45y or older) with a diagnosis of CP (n=5176). Adults without a diagnosis of CP were included as a typically developing comparison group (n=1 119 131). Using age, sex, ethnicity, other demographic variables, and a set of chronic morbidities, we propensity‐matched individuals with and without CP (n=5038). Cox survival models were used to estimate ADRD risk within a 3‐year follow up.
Results
The unadjusted incidence of ADRD was 9 and 2.4 times higher among cohorts of adults 45 to 64 years (1.8%) and 65 years and older (4.8%) with CP than the respective unmatched individuals without CP (0.2% and 2.0% among 45–64y and 65y or older respectively). Fully adjusted survival models indicated that adults with CP had a greater hazard for ADRD (among 45–64y: unmatched hazard ratio 7.48 [95% confidence interval {CI} 6.05–9.25], matched hazard ratio 4.73 [95% CI 2.72–8.29]; among 65y or older: unmatched hazard ratio 2.21 [95% CI 1.95–2.51], matched hazard ratio 1.73 [1.39–2.15]).
Interpretation
Clinical guidelines for early screening of cognitive function among individuals with CP need updating, and preventative and/or therapeutic services should be used to reduce the risk of ADRD.
This original article is commented by Engelborghs on page 284 of this issue. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0012-1622 1469-8749 |
DOI: | 10.1111/dmcn.15044 |